Kyverna Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Kyverna Therapeutics stock have an average target of 20.75, with a low estimate of 5.00 and a high estimate of 33. The average target predicts an increase of 156.17% from the current stock price of 8.10.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$20.75	$25	$33
Change	-38.27%	+156.17%	+208.64%	+307.41%

* Price targets were last updated on Dec 16, 2025.

Analyst Ratings

The average analyst rating for Kyverna Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	3	2	2	2	2	2
Buy	3	3	3	3	3	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $31 → $33	Buy	Maintains	$31 → $33	+307.41%	Dec 16, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $20 → $25	Buy	Maintains	$20 → $25	+208.64%	Dec 4, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $27 → $31	Buy	Maintains	$27 → $31	+282.72%	Oct 30, 2025
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $10 → $20	Strong Buy	Maintains	$10 → $20	+146.91%	Oct 27, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $24 → $27	Buy	Maintains	$24 → $27	+233.33%	Oct 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-3.78

from -3.33

EPS Next Year

-3.56

from -3.78

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	5.66M	7.03M	-	-	-	-	27.47M
Revenue Growth	-	24.20%	-	-	-	-	-
EPS	-99.10	-63.43	-89.61	-3.33	-3.78	-3.56	-3.29
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	8	8	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-3.60	-3.06
Avg	-3.78	-3.56
Low	-3.93	-3.80

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.